ArticleBMJ public health2026
Knowledge, perceived harms and reasons for use of disposable electronic cigarettes among youth: a qualitative study in Switzerland.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Disposable electronic cigarettes (DECs) have rapidly gained popularity among adolescents and young adults (AYAs), raising public health concerns related to nicotine dependence, exposure to potentially harmful substances and environmental burden. While motivations for e-cigarette use have been explored, little is known about how AYAs perceive and use DECs, in particular within a changing regulatory context such as Switzerland. Objectives: This qualitative study explored AYA's knowledge, perceived harms and reasons for DEC use through a developmental lens, to better understand vulnerabilities specific to this age and inform prevention strategies targeting this population. Methods: Eight focus groups were conducted via videoconference between October and December 2022 with 51 participants aged 14-25 years living in the Swiss cantons of Vaud and Valais. Discussions were transcribed, anonymised and analysed using a thematic analysis approach. Results: While DECs were largely known and consumed, participants had limited and often imprecise knowledge regarding product composition and nicotine content. Perception of harm was heterogeneous and influenced by packaging and insufficient product information. DEC use was primarily described as driven by experimentation, transgression, peer dynamics and identity construction rather than by nicotine effects, although nicotine addiction was sometimes described as a consequence of use. DECs were often described as interchangeable with conventional cigarettes. Accessibility and marketing features such as flavours, design and social media visibility were central to product appeal. Differences in cantonal legislation did not seem to clearly influence perceptions or reported behaviours. Conclusions: DEC use among AYAs reflects both developmental vulnerabilities and the influence of targeted marketing strategies. Alongside age restrictions, effective prevention should address product design, marketing and packaging practices, as well as information transparency. Further research on vaping-related harms is needed to inform healthcare professionals, and surveillance of DEC and other tobacco-derived product use following legislative changes will be essential to guide future regulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.